{"id":"NCT01768286","sponsor":"Gilead Sciences","briefTitle":"Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection","officialTitle":"A Phase 3, Multicenter, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5885 Fixed-Dose Combination ± Ribavirin for 12 and 24 Weeks in Treatment-Experienced Subjects With Chronic Genotype 1 HCV Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-01","primaryCompletion":"2013-11","completion":"2014-02","firstPosted":"2013-01-15","resultsPosted":"2014-11-26","lastUpdate":"2018-11-16"},"enrollment":441,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Hepatitis C Virus"],"interventions":[{"type":"DRUG","name":"LDV/SOF","otherNames":["Harvoni®","GS-5885/GS-7997"]},{"type":"DRUG","name":"RBV","otherNames":[]}],"arms":[{"label":"LDV/SOF 12 Weeks","type":"EXPERIMENTAL"},{"label":"LDV/SOF+RBV 12 Weeks","type":"EXPERIMENTAL"},{"label":"LDV/SOF 24 Weeks","type":"EXPERIMENTAL"},{"label":"LDV/SOF+RBV 24 Weeks","type":"EXPERIMENTAL"}],"summary":"This study is to evaluate the safety, tolerability, and antiviral efficacy of ledipasvir/sofosbuvir fixed dose combination (FDC) with or without ribavirin (RBV) administered for 12 or 24 weeks in treatment-experienced subjects with chronic genotype 1 hepatitis C virus (HCV) infection.","primaryOutcome":{"measure":"Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12)","timeFrame":"Posttreatment Week 12","effectByArm":[{"arm":"LDV/SOF 12 Weeks","deltaMin":93.6,"sd":null},{"arm":"LDV/SOF+RBV 12 Weeks","deltaMin":96.4,"sd":null},{"arm":"LDV/SOF 24 Weeks","deltaMin":99.1,"sd":null},{"arm":"LDV/SOF+RBV 24 Weeks","deltaMin":99.1,"sd":null}],"pValues":[{"comp":"OG000","p":"<0.001"},{"comp":"OG001","p":"<0.001"},{"comp":"OG002","p":"<0.001"},{"comp":"OG003","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":53,"countries":["United States"]},"refs":{"pmids":["27553375","24725238"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":109},"commonTop":["Fatigue","Headache","Nausea","Insomnia","Arthralgia"]}}